Polymorphisms of the Cytokine Genes and their Implication in Transplantation;Polymorfismy Cytokinových Genů a jejich Význam pro Transplantace

Alergie

Volumn 6, Issue 1, 2004, Pages 58-61

  Mrázek, František ^a   Petřek, Martin ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Genetic risk; Graft rejection; GvHD; Prophylaxis; Transplant complications

Indexed keywords

CYTOKINE; HLA ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN;

CYTOKINE PRODUCTION; GENETIC POLYMORPHISM; GENETIC RISK; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; REVIEW;

EID: 1842811226     PISSN: 12123536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Akalin E, Murphy B. Gene polymorphisms and transplantation. Curr Opin Immunol 2001; 13: 572-576.
2. Asderakis A, Sankaran D, Dyer P, Johnson RW, Pravica V, Sinnott PJ, Roberts I, Hutchinson IV. Association of polymorphisms in the human interferon-gamma and interleukin-10 gene with acute and chronic kidney transplant outcome: the cytokine effect on transplantation. Transplantation 2001; 71: 674-677.
3. Bathgate AJ, Pravica V, Perrey C, Therapondos G, Plevris JN, Hayes PC, Hutchinson IV. The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta 1 genes in acute hepatic allograft rejection. Transplantation 2000; 69: 1514-1517.
4. Bensinger WI, Storb R. Allogeneic peripheral blood stem cell transplantation. Rev Clin Exp Hematol 2001; 5: 67-86.
5. Cavet J, Dickinson AM, Norden J, Taylor PR, Jackson GH, Middleton PG. Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Blood 2001; 98: 1594-1600.
6. Cavet J, Middleton PG, Segall M, Noreen H, Davies SM, Dickinson AM. Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood 1999; 94: 3941-3946.
7. Cullup H, Dickinson AM, Cavet J, Jackson GH, Middleton PG. Polymorphisms of interleukin-1alpha constitute independent risk factors for chronic graft-versus-host disease after allogeneic bone marrow transplantation. Br J Haematol 2003; 122: 778-787.
8. Cullup H, Dickinson AM, Jackson GH, Taylor PR, Cavet J, Middleton PG. Donor interleukin 1 receptor antagonist genotype associated with acute graft-versus-host disease in human leucocyte antigen-matched sibling allogeneic transplants. Br J Haematol 2001; 113: 807-813.
9. Dickinson AM, Cavet J, Cullup H, Wang XN, Sviland L, Middleton PG. GvHD risk assessment in hematopoietic stem cell transplantation: role of cytokine gene polymorphisms and an in vitro human skin explant model. Hum Immunol 2001; 62: 1266-1276.
10. Farag SS, Fehniger TA, Ruggeri L, Velardi A, Caligiuri MA. Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. Blood 2002; 100: 1935-1947.
11. George S, Turner D, Reynard M, Navarrete C, Rizvi I, Fernando ON, Powis SH, Moorhead JF, Varghese Z. Significance of cytokine gene polymorphism in renal transplantation. Transplant Proc 2001; 33: 483-484.
12. Goker H, Haznedaroglu IC, Chao NJ. Acute graft-vs-host disease: pathobiology and management. Exp Hematol 2001; 29: 259-277.
13. Goulmy E. Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunol Rev 1997; 157: 125-140.
14. Hahn AB, Kasten-Jolly JC, Constantino DM, Graffunder E, Singh TP, Shen GK, Conti DJ. TNF-alpha, IL-6, IFN-gamma, and IL-10 gene expression polymorphisms and the IL-4 receptor alpha-chain variant Q576R: effects on renal allograft outcome. Transplantation 2001; 72: 660-665.
15. Hansen JA, Yamamoto K, Petersdorf E, Sasazuki T. The role of HLA matching in hematopoietic cell transplantation. Rev Immunogenet 1999; 1: 359-373.
16. Hattori H, Matsuzaki A, Suminoe A, Ihara K, Nagatoshi Y, Sakata N, Kawa K, Okamura J, Hara T. Polymorphisms of transforming growth factor-beta 1 and transforming growth factor-beta 1 type II receptor genes are associated with acute graft-versus-host disease in children with HLA-matched sibling bone marrow transplantation. Bone Marrow Transplant 2002; 30: 665-671.
17. Hoffmann SC, Stanley EM, Cox ED, DiMercurio BS, Koziol DE, Harlan DM, Kirk AD, Blair PJ. Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2002; 2: 560-567.
18. Lacha J, Hubacek JA, Viklicky O, Malek I, Hutchinson I, Vitko S. TGF-beta 1 gene polymorphism is a risk factor for renal dysfunction in heart transplant recipients. Transplant Proc 2001; 33: 1567-1569.
19. Lin MT, Storer B, Martin PJ, Tseng LH, Gooley T, Chen PJ, Hansen JA. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med 2003; 349: 2201-2210.
20. MacMillan ML, Radloff GA, DeFor TE, Weisdorf DJ, Davies SM. Interleukin-1 genotype and outcome of unrelated donor bone marrow transplantation. Br J Haematol 2003; 121: 597-604.
21. MacMillan ML, Radloff GA, Kiffmeyer WR, DeFor TE, Weisdorf DJ, Davies SM. High-producer interleukin-2 genotype increases risk for acute graft-versus-host disease after unrelated donor bone marrow transplantation. Transplantation 2003; 76: 1758-1762.
22. Marshall SE, McLaren AJ, McKinney EF, Bird TG, Haldar NA, Bunce M, Morris PJ, Welsh KI. Donor cytokine genotype influences the development of acute rejection after renal transplantation. Transplantation 2001; 71: 469-476.
23. Marshall SE, Welsh KI. The role of cytokine polymorphisms in rejection after solid organ transplantation. Genes Immun 2001; 2: 297-303.
24. Middleton PG, Taylor PR, Jackson G, Proctor SJ, Dickinson AM. Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants. Blood 1998; 92: 3943-3948.
25. Morgun A, Shulzhenko N, Rampim GF, Medina JO, Machado PG, Diniz RV, Almeida DR, Gerbase-DeLima M. Interleukin-2 gene polymorphism is associated with renal but not cardiac transplant outcome. Transplant Proc 2003; 35: 1344-1345.
26. Muller-Steinhardt M, Hartel C, Muller B, Kirchner H, Fricke L. The interleukin-6-174 promoter polymorphism is associated with long-term kidney allograft survival. Kidney Int 2002; 62: 1824-1827.
27. Opelz G, Wujciak T, Dohler B, Scherer S, Mytilineos J. HLA compatibility and organ transplant survival. Collaborative Transplant Study. Rev Immunogenet 1999; 1: 334-342.
28. Petřek M: Hlavni histokompatibilní komplex člověka (HLA) v klinické imunologii: nomenklatura a možnosti laboratorní diagnostiky. Alergie 2000; 2: 155-160. (www.tigis.cz)
29. Poli F, Boschiero L, Giannoni F, Tonini M, Ancona G, Scalamogna M, Berra S, Sirchia G. TNF-alpha IFN-gamma IL-6, IL-10, and TGF-beta 1 gene polymorphisms in renal allografts. Transplant Proc 2001; 33: 348-349.
30. Poole KL, Gibbs PJ, Evans PR, Sadek SA, Howell WM. Influence of patient and donor cytokine genotypes on renal allograft rejection: evidence from a single centre study. Transpl Immunol 2001; 8: 259-265.
31. Sahoo S, Kang S, Supran S, Saloman R, Wolfe H, Freeman RB: Tumor necrosis factor genetic polymorphisms correlate with infections after renal transplantation. Transplantation 2000; 69: 880-884.
32. Slavcev A, Bendukidze N, Mytilineos J, Ivaskova E, Striz I. Cytokine gene polymorphisms in the Czech population (Abstract). Tissue Antigens 2002; 59(Suppl 2):P8.4.
33. Slavcev A. Mechanisms of allorecognition and organ transplant rejection. Ann Transplant 2001; 6: 5-8.
34. Socie G, Loiseau P, Tamouza R, Janin A, Busson M, Gluckman E, Charron D. Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation 2001; 72: 699-706.
35. Takahashi H, Furukawa T, Hashimoto S, Suzuki N, Kuroha T, Yamazaki F, Inano K, Takahashi M, Aizawa Y, Koike T. Contribution of TNF-alpha and IL-10 gene polymorphisms to graft-versus-host disease following allo-hematopoietic stem cell transplantation. Bone Marrow Transplant 2000; 26: 1317-1323.
36. Turner DM, Grant SC, Lamb WR, Brenchley PE, Dyer PA, Sinnott PJ, Hutchinson IV. A genetic marker of high TNF-alpha production in heart transplant recipients. Transplantation 1995; 60: 1113-1117.
37. Turner D, Grant SC, Yonan N, Sheldon S, Dyer PA, Sinnott PJ, Hutchinson IV: Cytokine gene polymorphism and heart transplant rejection. Transplantation 1997; 64: 776-779.